Ondansetron

Product NDC: 53002-0570
11-digit product format: 530020570
Labeler code: 53002
Product ID: 53002-0570_a24b048c-c7c1-4698-a7f8-43da2106bedc
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Ondansetron
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: RPK Pharmaceuticals, Inc.
Application: ANDA077851
Marketing category: ANDA
Marketing start: 2007-07-27
Marketing end: 0000-00-00
Substance: ONDANSETRON HYDROCHLORIDE
Active strength: 4 mg/1
Pharmacologic classes: Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	53002-0570		I	Inactivated by FDA	2026-08-17
excluded package	package	53002-0570	53002-0570-1	I	Inactivated by FDA	2026-08-17
excluded package	package	53002-0570	53002-0570-2	I	Inactivated by FDA	2026-08-17
excluded package	package	53002-0570	53002-0570-3	I	Inactivated by FDA	2026-08-17
excluded package	package	53002-0570	53002-0570-4	I	Inactivated by FDA	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 55 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-0570-4	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-0570-3	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-0570-2	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-0570-1	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-0570-4	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-0570-3	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-0570-2	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-0570-1	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-0570-4	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-0570-3	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-0570-2	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-0570-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-0570-4	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-0570-3	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-0570-2	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-0570-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-0570-4	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-0570-3	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-0570-2	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-0570-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-0570-4	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-0570-3	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-0570-2	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-0570-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-0570-3	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-0570-1	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-0570-4	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-0570-2	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-0570-3	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-0570-1	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-0570-4	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-0570-2	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-0570-3	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-0570-1	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-0570-4	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-0570-2	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-0570-4	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-0570-2	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-0570-1	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-0570-3	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-0570-2	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-0570-3	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-0570-4	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-0570-1	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077851-001	ONDANSETRON HYDROCHLORIDE	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB		2007-06-25
A077851-002	ONDANSETRON HYDROCHLORIDE	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB		2007-06-25

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A077851-001	AB
A077851-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077851-001	ONDANSETRON HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2007-06-25	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077851-002	ONDANSETRON HYDROCHLORIDE	EQ 8MG BASE	TABLET / ORAL	AB	2007-06-25	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A077851-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077851-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077851-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077851-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077851-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077851-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077851-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077851-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077851-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077851-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077851-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077851-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077851-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077851-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077851-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077851-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077851-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077851-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077851-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077851-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077851-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077851-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077851-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077851-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077851-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077851-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077851-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077851-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077851-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077851-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077851-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077851-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077851-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077851-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077851-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077851-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077851-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077851-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077851-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077851-002	AB	1	`bb7c543d1eb4…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d9bd4853-037c-6968-f4d4-9bb9a0efd1ea	Product name	2	20250722
32e23bc9-ce14-4555-bb6d-bcb654d7d296	Product name	1	20201015
e459f50a-1553-4aab-b6bd-1e5f0c211c49	Product name	1	20201015
909480fe-0d18-c1c1-a658-0bd9a7131822	Product name	5	20170829

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
53002-0570-1	2025-01-30	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-2	2025-01-30	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-3	2025-01-30	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-4	2025-01-30	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-1	2023-06-07	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-2	2023-06-07	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-3	2023-06-07	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-4	2023-06-07	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-1	2023-01-30	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-2	2023-01-30	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-3	2023-01-30	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-4	2023-01-30	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-1	2020-12-15	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-2	2020-12-15	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-3	2020-12-15	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-4	2020-12-15	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-1	2020-01-31	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-2	2020-01-31	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-3	2020-01-31	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991
53002-0570-4	2020-01-31	These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON Tablets USP, for oral use Initial U.S. Approval: 1991

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
53002-0570-1	Ondansetron	3 in 1 BOTTLE	TABLET, FILM COATED	3	5
53002-0570-2	Ondansetron	6 in 1 BOTTLE	TABLET, FILM COATED	6	5
53002-0570-3	Ondansetron	10 in 1 BOTTLE	TABLET, FILM COATED	10	5
53002-0570-4	Ondansetron	30 in 1 BOTTLE	TABLET, FILM COATED	30	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53002-0570	ONDANSETRON TABLET, FILM COATED [RPK PHARMACEUTICALS, INC.]	5	Legacy NDC, 4 package rows	20230609_4ae18cf9-450f-4b42-a11e-8506b5783f02.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ondansetron	ONDANSETRON HYDROCHLORIDE	Ascend Laboratories, LLC	2edc0788-dc38-4d21-ba8e-71f159e2d3b1	2026-07-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077851 application number: ANDA077851
Ondansetron	ONDANSETRON	REMEDYREPACK INC.	36592150-7e19-474c-9f96-cc8341e28b5d	2026-03-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077851 application number: ANDA077851
Ondansetron	ONDANSETRON	Golden State Medical Supply, Inc.	2b9ea1fc-59a4-8189-e063-6394a90a9ae6	2026-01-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077851 application number: ANDA077851
Ondansetron	ONDANSETRON	Natco Pharma USA LLC	64527de5-0b92-4340-9243-7a37e8ff96d9	2025-12-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077851 application number: ANDA077851
Ondansetron	ONDANSETRON	Bryant Ranch Prepack	f08f56de-8678-4da9-8cae-013a5c393453	2024-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077851 application number: ANDA077851
Ondansetron	ONDANSETRON TABLETS	Natco Pharma Limited	59c817b7-a1c6-48a5-9bfc-2c381532bfd9	2021-11-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077851 application number: ANDA077851
ondansetron	ONDANSETRON HYDROCHLORIDE	Proficient Rx LP	bde7c22c-0047-4735-8df6-b48e8dfa478a	2021-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077851 application number: ANDA077851
ONDANSETRON	ONDANSETRON	Proficient Rx LP	41c0dc3d-a616-425e-9073-625a0cb692c4	2019-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077851 application number: ANDA077851
ONDANSETRON	ONDANSETRON	Sun Pharmaceutical Industries, Inc.	834bc56a-657d-4733-9a60-47040cb5c7bf	2019-09-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077851 application number: ANDA077851
ondansetron	ONDANSETRON HYDROCHLORIDE	Bryant Ranch Prepack	37de0550-a6d1-46a8-a0b8-447b0dcf70ad	2019-06-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077851 application number: ANDA077851

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
NMH84OZK2B	ONDANSETRON HYDROCHLORIDE	103639-04-9	ONDANSETRON HYDROCHLORIDE
4AF302ESOS	ONDANSETRON	99614-02-5	Ondansetron

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198052	ondansetron HCl 4 MG Oral Tablet	PSN	4ae18cf9-450f-4b42-a11e-8506b5783f02	5
198052	ondansetron 4 MG Oral Tablet	SCD	4ae18cf9-450f-4b42-a11e-8506b5783f02	5
198052	ondansetron 4 MG (as ondansetron HCl dihydrate 5 MG) Oral Tablet	SY	4ae18cf9-450f-4b42-a11e-8506b5783f02	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
53002-0570-1	53002057001	3 TABLET, FILM COATED in 1 BOTTLE (53002-0570-1)	2017-10-01	0000-00-00	No	No	Current
53002-0570-2	53002057002	6 TABLET, FILM COATED in 1 BOTTLE (53002-0570-2)	2017-10-01	0000-00-00	No	No	Current
53002-0570-3	53002057003	10 TABLET, FILM COATED in 1 BOTTLE (53002-0570-3)	2017-10-01	0000-00-00	No	No	Current
53002-0570-4	53002057004	30 TABLET, FILM COATED in 1 BOTTLE (53002-0570-4)	2017-10-01	0000-00-00	No	No	Current